跳至主要内容
临床试验/IRCT201511274226N4
IRCT201511274226N4已完成未知

The effect of vitamin B12 supplementation on liver enzymes and viral load in nonresponding or early relapsing cases of chronic HCV hepatitis

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Exclusion criteria: age <18 or>70 year, concomitant causes of liver disease, such as hepatitis B virus infection, autoimmunity and alcohol abuse (>40 g/day for men and >20 g/day for women), HIV infection, hepatocellular carcinoma, decompensated cirrhosis, severe concurrent disease, contraindications to treatment with vitamin B12. age between 18 to70 years, Lack of concomitant causes of liver disease, such as hepatitis B virus infection, autoimmunity and alcohol abuse (>40 g/day for men and >20 g/day for women), Lack of HIV infection, Lack of hepatocellular carcinoma, Lack of decompensated cirrhosis, Lack of severe concurrent disease.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验

Vitamin B12 in chronic hepatitis C | 临床试验